King KL - Search Results

1

Development of MGD007, a gpA33 x CD3-Bispecific DART Protein for T-Cell Immunotherapy of Metastatic Colorectal Cancer.

Moore PA, Shah K, Yang Y, Alderson R, Roberts P, Long V, Liu D, Li JC, Burke S, Ciccarone V, Li H, Fieger CB, Hooley J, Easton A, Licea M, Gorlatov S, King KL, Young P, Adami A, Loo D, Chichili GR, Liu L, Smith DH, Brown JG, Chen FZ, Koenig S, Mather J, Bonvini E, Johnson S. Moore PA, et al. Among authors: king kl. Mol Cancer Ther. 2018 Aug;17(8):1761-1772. doi: 10.1158/1535-7163.MCT-17-1086. Epub 2018 Jun 4. Mol Cancer Ther. 2018. PMID: 29866746

2

Biological response to ErbB ligands in nontransformed cell lines correlates with a specific pattern of receptor expression.

Sundaresan S, Roberts PE, King KL, Sliwkowski MX, Mather JP. Sundaresan S, et al. Among authors: king kl. Endocrinology. 1998 Dec;139(12):4756-64. doi: 10.1210/endo.139.12.6378. Endocrinology. 1998. PMID: 9832411

3

Endogenous cardiac vasoactive factors modulate endothelin production by cardiac fibroblasts in culture.

King KL, Winer J, Mather JP. King KL, et al. Endocrine. 1996 Aug;5(1):95-102. doi: 10.1007/BF02738661. Endocrine. 1996. PMID: 21153099

4

Cardiac fibroblasts produce leukemia inhibitory factor and endothelin, which combine to induce cardiac myocyte hypertrophy in vitro.

King KL, Lai J, Winer J, Luis E, Yen R, Hooley J, Williams PM, Mather JP. King KL, et al. Endocrine. 1996 Aug;5(1):85-93. doi: 10.1007/BF02738660. Endocrine. 1996. PMID: 21153098

5

Phenylephrine, endothelin, prostaglandin F2alpha' and leukemia inhibitory factor induce different cardiac hypertrophy phenotypes in vitro.

King KL, Winer J, Phillips DM, Quach J, Williams PM, Mather JP. King KL, et al. Endocrine. 1998 Aug;9(1):45-55. doi: 10.1385/endo:9:1:45. Endocrine. 1998. PMID: 9798730

6

Receptor binding and biological activity of mammalian expressed sensory and motor neuron-derived factor (SMDF).

Osheroff PL, Tsai SP, Chiang NY, King KL, Li R, Lewis GD, Wong K, Henzel W, Mather J. Osheroff PL, et al. Among authors: king kl. Growth Factors. 1999;16(3):241-53. doi: 10.3109/08977199909002133. Growth Factors. 1999. PMID: 10372964

7

Expression of a parathyroid hormone-like protein and its receptor during differentiation of embryonal carcinoma cells.

Chan SD, Strewler GJ, King KL, Nissenson RA. Chan SD, et al. Among authors: king kl. Mol Endocrinol. 1990 Apr;4(4):638-46. doi: 10.1210/mend-4-4-638. Mol Endocrinol. 1990. PMID: 2177844

8

Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth.

Sarup JC, Johnson RM, King KL, Fendly BM, Lipari MT, Napier MA, Ullrich A, Shepard HM. Sarup JC, et al. Among authors: king kl. Growth Regul. 1991 Jun;1(2):72-82. Growth Regul. 1991. PMID: 1688187

9

Effects of kistrin on bone resorption in vitro and serum calcium in vivo.

King KL, D'Anza JJ, Bodary S, Pitti R, Siegel M, Lazarus RA, Dennis MS, Hammonds RG Jr, Kukreja SC. King KL, et al. J Bone Miner Res. 1994 Mar;9(3):381-7. doi: 10.1002/jbmr.5650090313. J Bone Miner Res. 1994. PMID: 8191932

10

Binding and cross-linking of 32P-labeled human relaxin to human uterine cells and primary rat atrial cardiomyocytes.

Osheroff PL, King KL. Osheroff PL, et al. Among authors: king kl. Endocrinology. 1995 Oct;136(10):4377-81. doi: 10.1210/endo.136.10.7664657. Endocrinology. 1995. PMID: 7664657

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters